Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavir

J Antimicrob Chemother. 2006 May;57(5):1016-7. doi: 10.1093/jac/dkl074. Epub 2006 Mar 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-Retroviral Agents / administration & dosage
  • Anti-Retroviral Agents / adverse effects*
  • Anti-Retroviral Agents / therapeutic use
  • Atazanavir Sulfate
  • Chemical and Drug Induced Liver Injury / epidemiology*
  • Chemical and Drug Induced Liver Injury / etiology
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Oligopeptides / administration & dosage
  • Oligopeptides / adverse effects*
  • Oligopeptides / therapeutic use
  • Pyridines / administration & dosage
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use
  • Spain

Substances

  • Anti-Retroviral Agents
  • Oligopeptides
  • Pyridines
  • Atazanavir Sulfate